Cite
HARVARD Citation
Torene, R. et al. (2017). Canakinumab reverses overexpression of inflammatory response genes in tumour necrosis factor receptor-associated periodic syndrome. Annals of the rheumatic diseases. 76 (1), pp. 303-309. [Online].